Raymond James & Associates’s Atlantic Capital Bancshares, Inc. Common Stock ACBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-10,667
Closed -$307K 4353
2021
Q4
$307K Hold
10,667
﹤0.01% 3425
2021
Q3
$283K Sell
10,667
-665
-6% -$16.2K ﹤0.01% 3459
2021
Q2
$289K Hold
11,332
﹤0.01% 3461
2021
Q1
$273K Hold
11,332
﹤0.01% 3421
2020
Q4
$180K Hold
11,332
﹤0.01% 3438
2020
Q3
$129K Sell
11,332
-23
-0.2% -$256 ﹤0.01% 3335
2020
Q2
$138K Buy
11,355
+23
+0.2% +$264 ﹤0.01% 3225
2020
Q1
$135K Sell
11,332
-502
-4% -$8.43K ﹤0.01% 3151
2019
Q4
$217K Sell
11,834
-1,321
-10% -$24.2K ﹤0.01% 3297
2019
Q3
$228K Buy
13,155
+3,000
+30% +$52.1K ﹤0.01% 3180
2019
Q2
$174K Hold
10,155
﹤0.01% 3310
2019
Q1
$181K Hold
10,155
﹤0.01% 3274
2018
Q4
$166K Hold
10,155
﹤0.01% 3205
2018
Q3
$170K Hold
10,155
﹤0.01% 3345
2018
Q2
$200K Hold
10,155
﹤0.01% 3261
2018
Q1
$184K Buy
+10,155
New +$180K ﹤0.01% 3160

Raymond James & Associates's ACBI Position: Q1 2022 in Review

Raymond James & Associates sold out of Atlantic Capital Bancshares, Inc. Common Stock (ACBI) in Q1 2022, closing a stake of 10,667 shares — an estimated $307K sold.

Raymond James & Associates first reported a position in ACBI in Q1 2018 and held it in 16 quarters. The position peaked at $307K in Q4 2021. 0 funds tracked by Wall St. Rank hold ACBI as of Q1 2022.

  • Raymond James & Associates reported no remaining Atlantic Capital Bancshares, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • Raymond James & Associates sold 10,667 Atlantic Capital Bancshares, Inc. Common Stock shares in Q1 2022, an estimated $307K.
  • Raymond James & Associates first reported a position in Atlantic Capital Bancshares, Inc. Common Stock in Q1 2018 and held it in 16 quarters.
  • Raymond James & Associates's Atlantic Capital Bancshares, Inc. Common Stock position peaked at $307K in Q4 2021.
  • 0 funds tracked by Wall St. Rank held Atlantic Capital Bancshares, Inc. Common Stock as of Q1 2022.

Based on Raymond James & Associates's 13F filing for Q1 2022, filed 11 May 2022.